Jamaica vs Republic of Moldova: Access to anti-retroviral drugs, female
Jamaica
62.0%
in 2024
Republic of Moldova
62.0%
in 2024
Jamaica rank
99th
Republic of Moldova rank
99th
Access to anti-retroviral drugs, female over time
- Jamaica
- Republic of Moldova
How they compare
Jamaica currently reports 62.0% against 62.0% in Republic of Moldova, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Republic of Moldova ahead.
Jamaica ranks 99th and Republic of Moldova ranks 99th of 141 countries.
Jamaica has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Jamaica | Republic of Moldova | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.8% | 1.4% | 4.4% | Jamaica |
| 2010s | 39.5% | 27.8% | 11.7% | Jamaica |
| 2020s | 59.0% | 56.4% | 2.6% | Jamaica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Jamaica or Republic of Moldova?
- Jamaica, at 62.0% against 62.0% in Republic of Moldova as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Jamaica and Republic of Moldova?
- 0.0%, with Jamaica ahead.
- How many years of comparable data are there for Jamaica and Republic of Moldova?
- 25 years are reported by both, from 2000 to 2024.
- How do Jamaica and Republic of Moldova rank globally for access to anti-retroviral drugs, female?
- Jamaica ranks 99th and Republic of Moldova ranks 99th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.